Ginkgo Bioworks
DNA, also known as Ginkgo Bioworks, operates as a biotechnology company that specializes in using genetic engineering to design microorganisms for various industries, including pharmaceuticals, agriculture, and food production. The company generates revenue by partnering with other firms to develop bespoke biological solutions and licensing its engineered organisms and technologies.
The ten most recent trades of Ginkgo Bioworks in all the Ark ETFs ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
---|---|---|---|---|
Aug 28, 2024 | Sell | $654 | 0.00% | 0.00% |
Aug 23, 2024 | Sell | $9,489 | 0.01% | 0.00% |
Aug 21, 2024 | Sell | $90,867 | 0.06% | 0.01% |
Aug 12, 2024 | Sell | $265,915 | 5.45% | 0.02% |
Aug 09, 2024 | Sell | $740,005 | 13.00% | 0.06% |
Aug 08, 2024 | Sell | $651,373 | 10.09% | 0.05% |
Aug 07, 2024 | Sell | $3,307,577 | 47.73% | 0.25% |
Aug 05, 2024 | Sell | $590,124 | 5.89% | 0.05% |
Jul 15, 2024 | Sell | $29 | 0.00% | 0.00% |
Jul 12, 2024 | Sell | $72 | 0.00% | 0.00% |